Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases
While chemoresistance in primary tumors is well-studied, much less is known about the influence of systemic chemotherapy on the development of drug resistance at metastatic sites. In this work, we use a hybrid spatial model of tumor response to a DNA damaging drug to study how the development of che...
Saved in:
Main Authors: | Ami B. Shah, Katarzyna A. Rejniak, Jana L. Gevertz |
---|---|
Format: | Article |
Language: | English |
Published: |
AIMS Press
2016-07-01
|
Series: | Mathematical Biosciences and Engineering |
Subjects: | |
Online Access: | https://www.aimspress.com/article/doi/10.3934/mbe.2016038 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
On drug resistance and metronomic chemotherapy: A mathematical modeling and optimal control approach
by: Urszula Ledzewicz, et al.
Published: (2017-01-01) -
MODERN POSSIBILITIES OF APPLICATION OF PREPARATION NAVELBINE® IN THE TREATMENT OF METASTATIC BREAST CANCER
by: L. V. Bolotina
Published: (2016-06-01) -
Anlotinib in combination with metronomic chemotherapy in HER2-negative metastatic breast cancer: an observational and retrospective study
by: Jiaxuan Liu, et al.
Published: (2025-01-01) -
Clinical Benefits of Metronomic Chemotherapy in Platinum-Refractory, Recurrent, and Metastatic Head and Neck Squamous Cell Carcinoma
by: Amira Elwan, et al.
Published: (2025-01-01) -
Phase I Trial of Upamostat Combined With Gemcitabine in Locally Unresectable or Metastatic Pancreatic Cancer: Safety and Preliminary Efficacy Assessment
by: Xiuping Lai, et al.
Published: (2025-01-01)